Apple to disable blood-oxygen feature on premium watches sold in US as part of patent dispute

Apple says it will disable a blood-oxygen monitoring feature on its two most popular watches in the U.S. beginning Thursday to comply with a court-ordered revival of a sales ban stemming from a patent dispute